Figure 2From: Long-term follow-up of cytogenetically normal CEBPA-mutated AMLOS and RFS in patients ≤/>60 years of age with bi CEBPA mutations compared to mo CEBPA mutations. (A) OS in patients ≤60 years (B) RFS in patients in CR ≤60 years (C) OS in patients > 60 years (D) RFS in patients in CR > 60 years. Abbreviations: biCEBPA, biallelic mutation in the CCAAT/enhancer-binding protein alpha; CI, confidence interval; CR, complete remission; moCEBPA, monoallelic mutation in the CCAAT/enhancer-binding protein alpha.Back to article page